Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor

US8772313B2 · kind B2 · utility

Assignees

• Abbott Laboratories · US
• Abb Vie Deutschland Gmbh & Co. KG · DE

Inventors

• Andreas Haupt · Ludwigshafen, DE
• Frauke Pohlki · Wiesbaden, DE
• Liliane Unger · Ludwigshafen, DE
• Ana-Lucia Relo · Ludwigshafen, DE
• Karsten Wicke · Ludwigshafen, DE
• Min Zhang · 安丰镇, CN

Key dates

• Filing date: Nov 1, 2011
• Grant date: Jul 8, 2014
• Expiry date: Nov 1, 2031

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D221/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to benzenesulfonyl or sulfonamide compounds of formulae IA and IBwherein the variables have the meanings given in the claims and the description, pharmaceutical compositions containing them, and their use in therapy. The compounds possess valuable therapeutic properties and are particularly suitable for treating diseases that respond to modulation of the serotonin 5-HT6 receptor.